United States (US) Parkinsons Disease Market (2025-2031) | Trends, Value, Industry, Competitive Landscape, Growth, Segmentation, Outlook, Forecast, Size & Revenue, Companies, Analysis, Share

Name: United States (US) Parkinsons Disease Market (2025-2031) | Trends & Value
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Drug Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-Inhibitors, Anticholinergics, Other Drugs), By Medical Devices (Deep Brain Stimulation (DBS) Devices, Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices), By Route of Administration (Oral, Transdermal, Subcutaneous, Intestinal Infusion, Others), By Distribution Channel (Hospital Pharmacies, Clinics, Retail Pharmacies, Online Pharmacies), By Patient Care Setting (Hospitals, Clinics) And Competitive Landscape

Product Code: ETC9972883	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Summon Dutta	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Parkinsons Disease Market Outlook
Market Size of United States (US) Parkinsons Disease Market, 2024
Forecast of United States (US) Parkinsons Disease Market, 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Revenues & Volume for the Period 2021- 2031
United States (US) Parkinsons Disease Market Trend Evolution
United States (US) Parkinsons Disease Market Drivers and Challenges
United States (US) Parkinsons Disease Price Trends
United States (US) Parkinsons Disease Porter's Five Forces
United States (US) Parkinsons Disease Industry Life Cycle
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Drug Class for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Levodopa/Carbidopa for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Dopamine Receptor Agonists for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By MAO-Inhibitors for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By COMT-Inhibitors for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Anticholinergics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Other Drugs for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Medical Devices for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Deep Brain Stimulation (DBS) Devices for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Route of Administration for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Oral for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Transdermal for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Subcutaneous for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Intestinal Infusion for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Clinics for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Retail Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Online Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Patient Care Setting for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Parkinsons Disease Market Revenues & Volume By Clinics for the Period 2021- 2031
United States (US) Parkinsons Disease Import Export Trade Statistics
Market Opportunity Assessment By Drug Class
Market Opportunity Assessment By Medical Devices
Market Opportunity Assessment By Route of Administration
Market Opportunity Assessment By Distribution Channel
Market Opportunity Assessment By Patient Care Setting
United States (US) Parkinsons Disease Top Companies Market Share
United States (US) Parkinsons Disease Competitive Benchmarking By Technical and Operational Parameters
United States (US) Parkinsons Disease Company Profiles
United States (US) Parkinsons Disease Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Parkinsons Disease Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Parkinsons Disease Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Parkinsons Disease Market - Industry Life Cycle

3.4 United States (US) Parkinsons Disease Market - Porter's Five Forces

3.5 United States (US) Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United States (US) Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F

3.7 United States (US) Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 United States (US) Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.9 United States (US) Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F

4 United States (US) Parkinsons Disease Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing aging population in the United States

4.2.2 Technological advancements in the treatment of Parkinson's disease

4.2.3 Growing awareness and early diagnosis initiatives

4.3 Market Restraints

4.3.1 High cost of Parkinson's disease medications and treatments

4.3.2 Lack of skilled healthcare professionals specializing in Parkinson's disease

4.3.3 Side effects and limited efficacy of current treatment options

5 United States (US) Parkinsons Disease Market Trends

6 United States (US) Parkinsons Disease Market, By Types

6.1 United States (US) Parkinsons Disease Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United States (US) Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United States (US) Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F

6.1.4 United States (US) Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F

6.1.5 United States (US) Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F

6.1.6 United States (US) Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F

6.1.7 United States (US) Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F

6.1.8 United States (US) Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F

6.2 United States (US) Parkinsons Disease Market, By Medical Devices

6.2.1 Overview and Analysis

6.2.2 United States (US) Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F

6.2.3 United States (US) Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F

6.3 United States (US) Parkinsons Disease Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United States (US) Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 United States (US) Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F

6.3.4 United States (US) Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.3.5 United States (US) Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F

6.3.6 United States (US) Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F

6.4 United States (US) Parkinsons Disease Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 United States (US) Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.4.3 United States (US) Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 United States (US) Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4.5 United States (US) Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

6.5 United States (US) Parkinsons Disease Market, By Patient Care Setting

6.5.1 Overview and Analysis

6.5.2 United States (US) Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 United States (US) Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

7 United States (US) Parkinsons Disease Market Import-Export Trade Statistics

7.1 United States (US) Parkinsons Disease Market Export to Major Countries

7.2 United States (US) Parkinsons Disease Market Imports from Major Countries

8 United States (US) Parkinsons Disease Market Key Performance Indicators

8.1 Average age of Parkinson's disease diagnosis in the United States

8.2 Number of clinical trials for new Parkinson's disease treatments

8.3 Percentage of Parkinson's disease patients receiving timely access to specialist care

8.4 Adoption rate of telemedicine and digital health solutions for Parkinson's disease management

9 United States (US) Parkinsons Disease Market - Opportunity Assessment

9.1 United States (US) Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United States (US) Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F

9.3 United States (US) Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 United States (US) Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.5 United States (US) Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F

10 United States (US) Parkinsons Disease Market - Competitive Landscape

10.1 United States (US) Parkinsons Disease Market Revenue Share, By Companies, 2024

10.2 United States (US) Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Germany Parkinsons Disease Market

Hungary Parkinsons Disease Market

India Parkinsons Disease Market

Indonesia Parkinsons Disease Market

Iraq Parkinsons Disease Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here